1. Home
  2. SSP vs EPRX Comparison

SSP vs EPRX Comparison

Compare SSP & EPRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SSP
  • EPRX
  • Stock Information
  • Founded
  • SSP 1878
  • EPRX 2011
  • Country
  • SSP United States
  • EPRX Canada
  • Employees
  • SSP N/A
  • EPRX N/A
  • Industry
  • SSP Broadcasting
  • EPRX
  • Sector
  • SSP Industrials
  • EPRX
  • Exchange
  • SSP Nasdaq
  • EPRX NYSE
  • Market Cap
  • SSP 158.9M
  • EPRX 130.0M
  • IPO Year
  • SSP 1988
  • EPRX N/A
  • Fundamental
  • Price
  • SSP $2.42
  • EPRX $3.02
  • Analyst Decision
  • SSP Buy
  • EPRX Strong Buy
  • Analyst Count
  • SSP 2
  • EPRX 1
  • Target Price
  • SSP $6.25
  • EPRX $9.00
  • AVG Volume (30 Days)
  • SSP 2.7M
  • EPRX 11.5K
  • Earning Date
  • SSP 05-08-2025
  • EPRX 05-07-2025
  • Dividend Yield
  • SSP N/A
  • EPRX N/A
  • EPS Growth
  • SSP N/A
  • EPRX N/A
  • EPS
  • SSP 1.01
  • EPRX N/A
  • Revenue
  • SSP $2,509,772,000.00
  • EPRX N/A
  • Revenue This Year
  • SSP N/A
  • EPRX N/A
  • Revenue Next Year
  • SSP $9.18
  • EPRX N/A
  • P/E Ratio
  • SSP $2.54
  • EPRX N/A
  • Revenue Growth
  • SSP 9.46
  • EPRX N/A
  • 52 Week Low
  • SSP $1.36
  • EPRX $2.20
  • 52 Week High
  • SSP $4.65
  • EPRX $4.48
  • Technical
  • Relative Strength Index (RSI)
  • SSP 45.52
  • EPRX N/A
  • Support Level
  • SSP $3.07
  • EPRX N/A
  • Resistance Level
  • SSP $3.81
  • EPRX N/A
  • Average True Range (ATR)
  • SSP 0.35
  • EPRX 0.00
  • MACD
  • SSP -0.09
  • EPRX 0.00
  • Stochastic Oscillator
  • SSP 2.80
  • EPRX 0.00

About SSP E.W. Scripps Company (The)

The E W Scripps Co is a media enterprise with interests in local and national media brands. It owns and operates a collection of daily and community newspapers in medium-sized cities in the southern and western portions of the United States. The company's operating segment includes Local Media, Scripps Networks, and Other. It generates maximum revenue from the Local Media segment. The Local Media segment includes local broadcast stations and their related digital operations.

About EPRX EUPRAXIA PHARMACEUTICALS INC

Eupraxia Pharmaceuticals Inc is a clinical-stage biotechnology company focused on the development of locally delivered, extended-release alternatives to existing pharmaceuticals. Its product EP-104 is used for the treatment of osteoarthritis and eosinophilic esophagitis symptoms. The company leverages its proprietary Diffusphere technology to optimize drug delivery for applications with significant unmet medical needs.

Share on Social Networks: